The molecular basis of ferroportin-linked hemochromatosis.
Mutations in the iron exporter ferroportin (Fpn) (IREG1, SLC40A1, and MTP1) result in hemochromatosis type IV, a disorder with a dominant genetic pattern of inheritance and heterogeneous clinical presentation. Most patients develop iron loading of Kupffer cells with relatively low saturation of plasma transferrin, but others present with high transferrin saturation and iron-loaded hepatocytes. We show that known human mutations introduced into mouse Fpn-GFP generate proteins that either are defective in cell surface localization or have a decreased ability to be internalized and degraded in response to hepcidin. Studies using co-immunoprecipitation of epitope-tagged Fpn and size-exclusion chromatography demonstrated that Fpn is multimeric. Both WT and mutant Fpn participate in the multimer, and mutant Fpn can affect the localization of WT Fpn, its stability, and its response to hepcidin. The behavior of mutant Fpn in cell culture and the ability of mutant Fpn to act as a dominant negative explain the dominant inheritance of the disease as well as the different patient phenotypes.
De Domenico
Ivana
I
Dipartimento di Scienze Microbiologiche Genetiche e Molecolari, Università di Messina, 98166 Messina, Italy.
Ward
Diane McVey
DM
Nemeth
Elizabeta
E
Vaughn
Michael B
MB
Musci
Giovanni
G
Ganz
Tomas
T
Kaplan
Jerry
J
D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000378:metabolism; D001665:Binding Sites; D027682:Cation Transport Proteins / Q000235:genetics*; D006367:HeLa Cells; D006432:Hemochromatosis / Q000235:genetics*; D064451:Hepcidins; D006801:Humans; D007501:Iron / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D015183:Restriction Mapping; D014168:Transferrin / Q000378:metabolism; D000098742:Ferroportin
D023181:Antimicrobial Cationic Peptides; D027682:Cation Transport Proteins; C578702:HAMP protein, human; C579599:Hamp protein, mouse; D064451:Hepcidins; D014168:Transferrin; D000098742:Ferroportin; D007501:Iron